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One of the important immunological factors in diseases is mannose binding lectin (MBL). The aim of 
present study is to determine the distribution of the alleles of mannose-binding lectin gene codon 52, 
54, 57 and promoter variants H/L, X/Y, P and Q in confirmed VL patients as an intracellular pathogen 
while compares with extracellular pathogens (in renal infection) and seek correlation between these 
variants and intracellular and extracellular infections. Fifty eight confirmed VL patients’ blood samples 
were compared with fifty eight blood samples of patients received renal in results of renal infections. 
MBL genotypes were investigated by polymerase chain reaction and restriction fragment length 
polymorphism. Frequency of defective allele B in extracellular pathogens was more than intracellular 
pathogens (P = 0.0001), and in contrary prevalence of wild type allele A in intracellular pathogens was 
more than extracellular pathogens (P = 0.0001), and in other alleles and variants there was not any 
significant difference. In conclusion, there was more prevalence of alleles with low mannose binding 
lectin serum level in extrallelular pathogens which can be consider as a risk factor for these infections. 
In other hand prevalence of high concentration alleles in intracellular pathogens indicate the role of 
mannose binding lectin level for susceptibility to intracellular pathogens.   
 





Different factors have interaction in pathogenesis of intra-
cellular and extracellular pathogens. Genetic factors are 
most important of them. Studies of twins have confirmed 
the importance of genetic factors in determining host sus-
ceptibility to infection with different pathogens (Comstock., 
1978; Lin et al., 1989). Recently several genes have been 
shown to affect susceptibility to intera and extracellular 
pathogens such as MHC alleles and different diseases. 
One of the important immunological factors in diseases is 
mannose binding lectin (MBL). Mannose-binding lectin is 
a member of the collectin family of proteins found in 
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acetylglucosamine and activates the complement system 
independently of antibodies via two associated serin pro-
tease, mannose binding lectin-associated serine protease 
1 and 2 (Jack et al., 2001; Mass et al., 1998; Thiel et al., 
1997). C1q and mannose binding lectin, as well as lung 
surfactant protein A, share the same phagocytic receptor, 
which is present on a variety of cells, including phago-
cytes, platelets, and endothelial cells (Nepomuceno et al., 
1999; Nepomuceno et al., 1998). 
Human mannose binding lectin is derived from a single 
gene on chromosome 10 (Sastry et al., 1989); the normal 
structural mannose binding lectin allele is named A, while 
the common designation for the 3 variant structural alleles 
B (mutation in codon 54, Gly to ASP), C (mutation in 
codon 57, Gly to Glu), and D (mutation in codon 52, Arg to 
Cys) are O (Hegele et al., 1999; Neth et al., 2001). 
In general,  individuals  with  a  normal  genotype  (A/A)  




Table 1. Oligonucleotides used in human MBL genotyping. 
 
Sequence of primers Origin of gene 
AG GCT GGG TAT ACC TAG GCT GAG Forward 
 CTC TTT CCT CCC GTT CTG TAC Reverse 
Codon 57 ( wild type ) 
AG GCT GGG TAT ACC TAG GCT GAG Forward 
 CTT TTT CCT CCC GTT CTG TAC Reverse 
Codon 57 ( mutant ) 
AG GCT GGG TAT ACC TAG GCT GAG Forward 
 GC GGT CTT TCC TTC CTT CCC Reverse 
Codon 54 (wild type ) 
AG GCT GGG TAT ACC TAG GCT GAG Forward 
 GT GGT CTT TCC TTC CTT CCC Reverse 
Codon 54 ( mutant ) 
 GC TGG AGA CAA AGG CCC CTT Forward 
 AGG GGA TCT TCC GTT GCA CAG Reverse 
Codon 52 (wild type ) 
 GT TGG AGA CAA AGG CCC CTT Forward 
 AGG GGA TCT TCC GTT GCA CAG Reverse 
Codon 52 ( mutant ) 
 GTG CCT AAG GGC CCA TAC GCT Forward 
 AGG GGA TCT TCC GTT GCA CAG reverse 
MBL allele H 
 GTC CCT AAG GGC CCA TAC GCT forward 
 AGG GGA TCT TCC GTT GCA CAG reverse 
MBL allele L 
 TC TGC GCA AGG CAG GGA GTA forward 
 AGG GGA TCT TCC GTT GCA CAG reverse 
MBL allele P 
 TT TGC GCA AGG CAG GGA GTA forward 
 AGG GGA TCT TCC GTT GCA CAG reverse 
MBL allele Q 
 GTG CCT AAG GGC CCA TAC GCT forward 
CC TTT TGC ACA TAA CTA AGA GGA reverse 
haplotypes Hy 
 GTC CCT AAG GGC CCA TAC GCT forward 
CC TTT TGC ACA TAA CTA AGA GGA reverse 
haplotypes Ly 
 GTC CCT AAG GGC CCA TAC GCT forward 
CG TTT TGC ACA TAA CTA AGA GGA reverse 
haplotypes Lx 
 GTG CTT AAG GGC CCA TAC GCT forward 





have mannose binding lectin concentration in serum that 
are 6 - 8 times higher that those in individuals heterozy-
gous for one of the variant alleles (A/O: A/B, A/C or A/D), 
while individuals with a defective genotype (2 variant alle-
les B/B, C/C, D/D, B/C, B/D or C/D) have almost undetec-
table mannose binding lectin serum levels (Garred et al., 
1999; Gradual et al., 2000; Dornelles et al., 2006 ). 
Moreover, mannose binding lectin expression is 
influenced by polymorphic sites in the upstream part of 
the mannose binding lectin gene (Crosdale et al., 2001; 
Ip et al., 1998). Nucleotides substitutions at position -550, 
-221 and +4 give rise to H/L, Y/X and P/Q, respectively 
and cause to different haplotypes, while LX haplotype is 
associated with low mannose binding lectin plasma levels 
(Santos et al., 2001; Soborg et al., 2003). 
In this study we investigated role of mannose binding 
lectin in leishmania infantum as an intracellular pathogen 
and renal infections as an extracellular pathogens to find 
relation of mannose binding lectin genetic diversity and 
pathogenesis of these infections.  




Blood samples were obtained from 58 confirmed visceral leishma-
niasis patients detected by clinical signs and direct smear and 
direct agglutination test and 58 patients with severe renal infection 
which had been caused to renal dysfunction. DNA was isolated 
from both granulocytes and mononuclear cells by the modified 





PCR was performed in 20 to 100 µl volumes that contained 50 to 
500 ng of genomic DNA, 0.5 µM of specific primers (Table 1) in the 
presence of 1.5 mM MgCl2, 100 µM of each dNTP, 50 mM KCl, 20 
mM Tris-HCl, pH 8.4, and 1 to 2.5 unit recombinant Taq DNA 
polymerase (Cinnagen, Iran). DNA was amplified by general PCR 
and SSP-PCR. All PCRs were initiated by a 4 min denaturation step 
at 94ºC and completed by a 7 min extension step at 72ºC. The 
temperature cycles for different types of PCRs were as follows. 32 
cycles of 40 s at 94ºC, annealing temperatures for 40 s and 72ºC 
for 55 s. Annealing temperatures which were used as follow: 60, 63,  













(n = 58) 
External pathogens 
(renal infection) 




Codon 54 mutation (Allele B) 6.9 35.34 0.0001 
Codon 57 mutation (Allele C) 1.7 6.9 0.3219 
Codon 52 mutation (Allele D) 3.45 9.48 0.1648 
Wild type (Allele A) 87.93 48.27 0.0001 
 
*Mannose-binding lectin variants frequency in patients and controls.  




Table 3. Frequency of promoter variants and positions -550 and + 4 in intracellular 












*Mannose-binding lectin Variants frequency in patients and controls.  




63, 62, 66, 63, 66, 67, 64, 67, 67, 65, 65,  and 66ºC for codon 57 
(wild type), 57 (mutant), codon 54 (wild type), 54 (mutant), codon 52 
(wild type), 52 (mutant), allele H, L, P, Q, haplotype Hy, Ly, Lx and 
Hx amplification, respectively (Crosdale et al., 2000; Madsen et al., 





In addition to SSP-PCR, B and C alleles were detected by BanI and 
MboII restriction enzyme digestion of the 320 bp product amplified 
by the alleles P and Q primers, respectively (Table 1), followed by a 
2.5% agarose gel electrophoresis. BanI cleaves the A allele into 
two fragments (245 and 83 bp) and leaves the B allele undigested, 
while MboII specifically cleaves the C allele into two fragments (266 





The distribution of alleles and genotypes between groups were 






The association between mannose binding lectin and 
pathogenesis of intracellular or extracellular pathogens 
cannot be explain by confounding factors such as diffe-
rence in age and disease duration (Garred et al., 1999). 
These overall frequencies differ significantly between 
intracellular and extracellular pathogens. Table 2 shows 
the frequency of defective allele B in extracellular patho-
gens was more than intracellular pathogens (P = 0.0001), 
and in contrary prevalence of wild type allele A in 
intracellular pathogens was more than extracellular 
pathogens (P = 0.0001). 
Frequency of promoter variants and position +4 (Table 
3) indicate that there is a prevalence of H variant in 
intracellular pathogens (P = 0.0652) and more prevalence 
of L variants in extracellular pathogens (P = 0.0652). 
Promoter haplotypes frequency in intracellular pathogens 
and extracellular pathogens were not significantly diffe-
rent and only a very rare haplotype of Hx in patients with 





In this study we investigated the association of exon 1 
and promoter haplotypes and pathogenesis upon intra-
cellular infection (leishmania infantum) and extracellular 
pathogen (renal infection). The results showed that geno- 






(n = 58) 
Internal pathogens 
(Leishmania infantum) 





0.0652 29.31 45.68 H 
0.0652 70.69 54.31 L 
1 74 74 P 
1 26 26 Q 













(n = 58) 
Internal pathogens 
(Leishmania infantum) 
(n = 58) 
 
Haplotypes 
0.4775 38.33 44.8 Hy 
0.3040 42.9 33.6 Ly 
0.7920 18.75 20.7 Lx 
0.4785 0 0.9 Hx 
 




types with high mannose binding lectin serum level were 
more frequent among patients with extracellular 
pathogens (renal infection) (P = 0.0001) and there was 
more prevalence of wild type genotype A in intracellular 
pathogen (P = 0.0001). Mannose binding lectin in gram 
negative organisms act as a complement activator to kill 
these organisms directly via the member attack complex 
or to enhance complement mediated phagocytosis, 
through the increased deposition of C3 fragments (Jack 
et al., 2001a). Previous studies about the role of man-
nose binding lectin in aspergillosis showed that codon 52 
mutation was particularly common demonstrating that 
mannose binding lectin low serum level as a risk factor 
for chronic necrotizing pulmonary aspergillosis (Crosdale 
et al., 2001). Previous studies in gram negative patho-
gens in our study and other extracellular pathogens 
studies confirmed that mannose binding lectin deficiency 
confer a long-life risk of these infections (Summerfield et 
al., 1995; Jack et al., 2001a). 
Also recent studies about relation of mannose binding 
lectin and Neisseria showed that this blood factor can 
bound to the surface of Neisseria and activate 
complement, which leads to an increase in bacterial 
killing (Jack et al., 1998; Jack et al., 2001a). Similar 
experiments have shown cidal activity of mannose 
binding lectin of Escherichia coli (Kawasaki et al., 1989) 
and Salmonella (Ihara et al., 1991). However some 
reports could not find any effect of mannose binding 
lectin on complement activation upon extracellular infec-
tion of Staphylococcus aureus (Cunion et al., 2001). 
In intracellular infections, there is conversion and 
deficiency confers protection against these infections. A 
new study suggests a protective role for mannose binding 
lectin deficiency against development of the most severe 
and multibacillary form of the leprosy (but not tuberculoid 
form) (Dornells et al., 2006). In tuberculosis, it has been 
demonstrated that heterozygosity for mannose binding 
lectin variant allele (XA/O), which encodes low serum 
mannose binding lectin level is associated with protection 
against clinical tuberculosis (Bellamy and Hill, 1998; 
Soborg et al., 2003). It has also been shown that lack of 
mannose binding lectin enhances survival in a mouse 
model of acute septic peritonitis (Takahashi et al., 2002).  
In some specific intracellular pathogens like Leishma-
nia, increasing concentration of mannose binding lectin 
cause increasing internalization of pathogens. Mannose 
binding lectin modulate the function of Leishmania 
chagasi-infected cells and high levels of circulating 
mannose binding lectin are directly correlated to the 
development of visceral leishmaniasis upon infection with 
Leishmania chagasi (Santos et al., 2001). Mannose 
binding lectin can promote the attachment of micro-
organisms to phagocytic cells (Jack and Turner, 2003) 
and increase the release of TNF-α and interleukin 6 from 
monocytes contaminated with parasite (Jack and Turner, 
2003). Also mannose binding lectin binds to the parasite 
surface and is most intense at base of the flagella in 
many parasites, on area of the plasma membrane that is 
the major site for exocytosis for these cells and contains 
a high concentration of surface antigen (Pimento et al., 
1991). Regarding mannose binding lectin role in the 
internalization of intracellular microorganism by phago-
cytic cells, it has been considered a candidate molecule 
for modifying the disease progression of intracellular 
pathogens (Ambrosio and Messias-Reason, 2005; 
Dornelles et al., 2006). This observation and our study 
suggest that mannose binding lectin deficiency could be 
advantageous to the host in intracellular pathogens but is 
completely dis-advantageous in the case of extracellular 
pathogens. It seems plausible that under certain circums-
tance, mannose binding lectin binding to pathogens 
would lead to excessive activation of complement being 
useful for the host defense against extracellular 
pathogens. 
In conclusion, our study confirmed that difference of 
mannose binding lectin gene variants can be a risk factor 
or protective factor in extracellular and intracellular 
pathogens. There is more prevalence of alleles with low 
mannose binding lectin serum level in extrallelular patho-
gens. In other hand, prevalence of high concentration 
alleles in intracellular pathogens indicates the role of 
mannose binding lectin level during susceptibility to intra-  
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